The commercial operations of ISTO Technologies, an orthobiologics company, were acquired by private equity firm Thompson Street Capital Partners. Transaction terms were not disclosed.
ISTO's portfolio includes InQu® Bone Graft Extender & Substitute, Influx® Trabecular Bone Graft and CellPoint® Concentrated Bone Marrow Aspirate System.
The company was established in 1997 and began to secure U.S. patents and attract funding shortly thereafter. Thompson Street plans to make investments and complementary acquisitions to support ISTO's product development, salesforce expansion and increase the company’s reach within spine and orthopaedics.
Sources: ISTO Technologies, ORTHOWORLD Inc.
The commercial operations of ISTO Technologies, an orthobiologics company, were acquired by private equity firm Thompson Street Capital Partners. Transaction terms were not disclosed. ISTO's portfolio includes InQu® Bone Graft Extender & Substitute, Influx® Trabecular Bone Graft and CellPoint® Concentrated...
The commercial operations of ISTO Technologies, an orthobiologics company, were acquired by private equity firm Thompson Street Capital Partners. Transaction terms were not disclosed.
ISTO's portfolio includes InQu® Bone Graft Extender & Substitute, Influx® Trabecular Bone Graft and CellPoint® Concentrated Bone Marrow Aspirate System.
The company was established in 1997 and began to secure U.S. patents and attract funding shortly thereafter. Thompson Street plans to make investments and complementary acquisitions to support ISTO's product development, salesforce expansion and increase the company’s reach within spine and orthopaedics.
Sources: ISTO Technologies, ORTHOWORLD Inc.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
